AF
RLYB icon

Allworth Financial’s Rallybio RLYB Stock Holding History

Allworth Financial’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96 Hold
6
– – ﹤0.01% 5026
2026
Q1 		$54 Hold
6
– – ﹤0.01% 5061
2025
Q4 		$35 Hold
6
– – ﹤0.01% 4879
2025
Q3 		$25 Hold
6
– – ﹤0.01% 4807
2025
Q2 		$17 Buy
+6
New +$16 ﹤0.01% 4528

Other funds holding RLYB

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Allworth Financial's RLYB Position: Q2 2026 in Review

Allworth Financial held its Rallybio (RLYB) position steady in Q2 2026 at 6 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #5026.

Allworth Financial first reported a position in RLYB in Q2 2025 and has held it in 5 quarters since. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Allworth Financial held 6 shares of Rallybio worth $96 as of Q2 2026.
  • Allworth Financial left its Rallybio share count unchanged in Q2 2026.
  • Rallybio made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5026 holding.
  • Allworth Financial first reported a position in Rallybio in Q2 2025 and has held it in 5 quarters since.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.